Shilanski & Associates, Inc. Eli Lilly & CO Transaction History
Shilanski & Associates, Inc.
- $296 Million
- Q2 2024
A detailed history of Shilanski & Associates, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Shilanski & Associates, Inc. holds 3,644 shares of LLY stock, worth $2.93 Million. This represents 1.11% of its overall portfolio holdings.
Number of Shares
3,644
Previous 3,766
3.24%
Holding current value
$2.93 Million
Previous $2.93 Million
12.63%
% of portfolio
1.11%
Previous 1.01%
Shares
8 transactions
Others Institutions Holding LLY
# of Institutions
3,771Shares Held
737MCall Options Held
7.09MPut Options Held
7.22M-
Lilly Endowment Inc Indianapolis, IN97.4MShares$78.3 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA72.7MShares$58.5 Billion1.14% of portfolio
-
Black Rock Inc. New York, NY65.3MShares$52.5 Billion1.2% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$41.4 Billion27.92% of portfolio
-
State Street Corp Boston, MA34.3MShares$27.6 Billion1.21% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $765B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...